UNBS 1450

Known as: UNBS-1450, UNBS1450 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2017
012320062017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A limiting factor in the therapeutic outcome of children with high-risk neuroblastoma is the intrinsic and acquired resistance to… (More)
  • figure 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
Cardiac steroids are used to treat various diseases including congestive heart failure and cancer. The aim of this study was to… (More)
Is this relevant?
2011
2011
Recent studies revealed the potential of Na(+)/K(+)-ATPase as a target for anticancer therapy and showed additional modes of… (More)
Is this relevant?
2009
2009
Melanomas remain associated with dismal prognosis because they are naturally resistant to apoptosis and they markedly metastasize… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
OBJECTIVE Ion transporters play pivotal roles in cancer cell migration in general and in glioblastomas (GBMs) in particular… (More)
Is this relevant?
2008
2008
The use of cardenolides like ouabain, digitoxin, or oleandrin has been reported previously many times as a means of potentially… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
With an overall 5 year survival rate as low as 15% for non-small cell lung cancer (NSCLC), even with surgical intervention and… (More)
Is this relevant?
2006
2006
Non-small cell lung cancers (NSCLCs) are the leading cause of cancer deaths in most developed countries. Targeting heat shock… (More)
Is this relevant?
2006
2006
Non-small cell lung cancers (NSCLC) are associated with very dismal prognoses, and adjuvant chemotherapy, including irinotecan… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
Non–small cell lung cancers (NSCLC) are associated with very dismal prognoses, and adjuvant chemotherapy, including irinotecan… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?